Clinical Trials Directory

Trials / Conditions / Extraocular Extension Melanoma

Extraocular Extension Melanoma

10 registered clinical trials studyying Extraocular Extension Melanoma.

StatusTrialSponsorPhase
TerminatedRadioembolization and Ipilimumab in Treating Patients With Uveal Melanoma With Liver Metastases
NCT01730157
Case Comprehensive Cancer CenterEARLY_Phase 1
TerminatedAxitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed by Surgery
NCT01533948
Roswell Park Cancer InstitutePhase 2
CompletedSorafenib, Carboplatin, and Paclitaxel in Treating Patients With Stage IV Melanoma of the Eye
NCT00329641
National Cancer Institute (NCI)Phase 2
CompletedVEGF Trap in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
NCT00450255
National Cancer Institute (NCI)Phase 2
CompletedAZD2171 in Treating Patients With Recurrent or Stage IV Melanoma
NCT00243061
National Cancer Institute (NCI)Phase 2
CompletedBortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma
NCT00288041
National Cancer Institute (NCI)Phase 2
CompletedVorinostat in Treating Patients With Metastatic or Unresectable Melanoma
NCT00121225
National Cancer Institute (NCI)Phase 2
CompletedVaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for Melanoma
NCT00089063
National Cancer Institute (NCI)Phase 2
CompletedVaccine Therapy in Treating Patients With Stage IIC-IV Melanoma
NCT00085189
University of Southern CaliforniaPhase 2
CompletedVaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye
NCT00020475
National Cancer Institute (NCI)Phase 2